Status:

COMPLETED

Convalescent Plasma Treatment in COVID-19

Lead Sponsor:

Aga Khan University

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred initially in December 2019 in the city of Wuhan, Hubei province, China. Patients mainly presented with respiratory...

Detailed Description

Objective: To investigate the efficacy and safety of transfusing convalescent plasma collected from patients who have recovered from COVID-19 disease to patients admitted at Aga Khan University Hospi...

Eligibility Criteria

Inclusion

  • Inclusion Criteria For Patients:
  • i. Inpatients at AKU with positive SARS-CoV-2 infection by rRT-PCR and who have provided written informed consent for inclusion in the trial;
  • ii. Age ≥ 18 years;
  • iii. Severe or immediately life-threatening COVID-19 defined by any of:
  • Respiratory rate ≥ 30/min;
  • Blood oxygen saturation ≤ 93% at room air;
  • Partial pressure of arterial Oxygen to Fraction of inspired Oxygen ratio \< 300;
  • Lung infiltrates \> 50% within 24 to 48 hours on radiology ( X-ray or CT scan);
  • Need for mechanical ventilation.
  • respiratory failure
  • septic shock
  • multiple organ dysfunction or failure
  • Exclusion Criteria for patients:
  • i. Negative rRT-PCR from respiratory secretions or blood within 48 h prior to assessment of eligibility.
  • ii. History of allergic reaction to blood or plasma products (as judged by the investigator).
  • iii. Medical conditions in which receipt of 500 mL intravascular volume may be detrimental to the patient (e.g., actively decompensated congestive heart failure).
  • iv. Enrollment in any other clinical trial for an investigational therapy

Exclusion

    Key Trial Info

    Start Date :

    April 26 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 10 2020

    Estimated Enrollment :

    110 Patients enrolled

    Trial Details

    Trial ID

    NCT04476888

    Start Date

    April 26 2020

    End Date

    October 10 2020

    Last Update

    January 20 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Aga Khan University Hospital

    Karachi, Sindh, Pakistan